NOVARTIS AG-REG (NOT.DE) Forecast, Price Target & Analyst Ratings

FRA:NOT • CH0012005267

Current stock price

122.94 EUR
-3.62 (-2.86%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for NOVARTIS AG-REG (NOT.DE).

Forecast Snapshot

Consensus Price Target

Price Target
€137.82
+ 12.10% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Apr 28, 2026
Period
Q1 / 2026
EPS Estimate
$2.18
Revenue Estimate
13.921B
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
70.59%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
€137.82
Upside
+ 12.10%
From current price of €122.94 to mean target of €137.82, Based on 34 analyst forecasts
Low
€99.79
Median
€140.47
High
€205.21

Price Target Revisions

1 Month
4.01%
3 Months
18.27%

Price Target Summary

34 Wall Street analysts provided a forecast for the next 12 months for NOT.DE. The average price target is 137.82 EUR. This implies a price increase of 12.1% is expected in the next year compared to the current price of 122.94.
The average price target has been revised upward by 18.27% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

NOT Current Analyst RatingNOT Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10

Analyst Ratings History

NOT Historical Analyst RatingsNOT Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 10 20 30

Analyst Ratings Consensus

ChartMill Buy Consensus
70.59%
NOT.DE was analyzed by 34 analysts. The buy percentage consensus is at 71. So analysts seem to be have mildly positive about NOT.DE.
In the previous month the buy percentage consensus was at a similar level.
NOT.DE was analyzed by 34 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

Next Earnings Forecast Details

Next Earnings Details

Release Date
Apr 28, 2026
Period
Q1 / 2026
EPS Estimate
$2.18
Revenue Estimate
13.921B
Revenue Q2Q
5.20%
EPS Q2Q
-4.59%
Number of Analysts
8

Next Earnings Revisions

Revenue (1 Month)
0.69%
Revenue (3 Months)
-0.55%
EPS (1 Month)
1.12%
EPS (3 Months)
-4.31%

Next Earnings Summary

NOT.DE is expected to report earnings on 4/28/2026. The consensus EPS estimate for the next earnings is 2.18 EUR and the consensus revenue estimate is 13.92B EUR.
The next earnings revenue estimate has been revised downward by 0.55% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
NOT.DE revenue by date.NOT.DE revenue by date.
46.66B
7.57%		51.722B
10.85%		56.33B
8.91%		57.976B
2.92%		61.029B
5.27%		64.704B
6.02%		70.78B
9.39%		73.405B
3.71%		70B
-4.64%		66.063B
-5.62%		64.5B
-2.37%
EBITDA
YoY % growth
NOT.DE ebitda by date.NOT.DE ebitda by date.
20.919B
20.31%		20.919B24.017B
14.81%		23.935B
-0.34%		25.526B
6.65%		27.417B
7.41%		32.466B
18.42%		33.974B
4.64%		31.883B
-6.15%		30.442B
-4.52%		29.726B
-2.35%
EBIT
YoY % growth
NOT.DE ebit by date.NOT.DE ebit by date.
12.642B
23.87%		16.32B
29.09%		18.692B
14.53%		20.869B
11.65%		22.308B
6.90%		23.981B
7.50%		28.436B
18.58%		30.361B
6.77%		30.574B
0.70%		28.808B
-5.78%		28.693B
-0.40%
Operating Margin
NOT.DE operating margin by date.NOT.DE operating margin by date.
27.09%31.55%33.18%36.00%36.55%37.06%40.18%41.36%43.68%43.61%44.49%
EPS
YoY % growth
NOT.DE eps by date.NOT.DE eps by date.
6.90
12.75%		7.81
13.19%		8.98
14.98%		8.97
-0.14%		9.83
9.63%		10.74
9.25%		12.19
13.46%		12.89
5.75%		13.14
1.99%		12.72
-3.24%		12.45
-2.13%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		2.18
-4.59%		2.25
-6.96%		2.30
2.05%		2.21
9.09%		2.30
5.55%		2.42
7.37%		2.46
6.97%		2.46
11.27%
Revenue
Q2Q % growth		13.921B
5.20%		14.405B
2.50%		14.715B
5.79%		15.062B
12.94%		14.096B
1.26%		14.688B
1.96%		14.928B
1.45%		15.05B
-0.08%
EBITDA
Q2Q % growth		4.84B
-18.52%		5.087B
-32.76%		5.007B
-40.10%		5.284B
-44.33%		N/AN/AN/AN/A
EBIT
Q2Q % growth		5.231B
9.30%		5.306B
2.93%		5.43B
18.43%		5.165B
23.98%		N/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

NOT.DE Yearly Revenue VS EstimatesNOT.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B
NOT.DE Yearly EPS VS EstimatesNOT.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
6.15%
EPS Next 5 Year
7.49%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
4.58%
Revenue Next 5 Year
5.35%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
8.86%
EBIT Next 5 Year
9.84%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

NOVARTIS AG-REG / NOT.DE Forecast FAQ

What do analysts expect the price target to be for NOVARTIS AG-REG (NOT.DE)?

34 analysts have analysed NOT.DE and the average price target is 137.82 EUR. This implies a price increase of 12.1% is expected in the next year compared to the current price of 122.94.

When does NOVARTIS AG-REG (NOT.DE) report earnings?

NOVARTIS AG-REG (NOT.DE) will report earnings on 2026-04-28, before the market open.

Can you provide the consensus estimates for NOVARTIS AG-REG next earnings?

The consensus EPS estimate for the next earnings of NOVARTIS AG-REG (NOT.DE) is 2.18 EUR and the consensus revenue estimate is 13.92B EUR.

Can you provide the expected long term growth rate for NOVARTIS AG-REG stock?

The expected long term growth rate for NOVARTIS AG-REG (NOT.DE) is 4.58%.